BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9151801)

  • 21. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Positive association of apolipoprotein B gene C7673T polymorphism with cerebral hemorrhage with family history].
    Zhang L; Yang QD; Zeng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):145-9. PubMed ID: 18393233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
    Rabès JP; Varret M; Saint-Jore B; Erlich D; Jondeau G; Krempf M; Giraudet P; Junien C; Boileau C
    Hum Mutat; 1997; 10(2):160-3. PubMed ID: 9259199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
    Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations.
    Liyanage KE; Hooper AJ; Defesche JC; Burnett JR; van Bockxmeer FM
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):170-6. PubMed ID: 18325181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia.
    Meriño-Ibarra E; Castillo S; Mozas P; Cenarro A; Martorell E; Díaz JL; Suárez-Tembra M; Alonso R; Civeira F; Mata P; Pocoví M;
    Hum Biol; 2005 Oct; 77(5):663-73. PubMed ID: 16596945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
    Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
    Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
    Falcó C; Estellés A; Dalmau J; España F; Aznar J
    Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
    J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major locus inheritance of apolipoprotein B in Utah pedigrees.
    Hasstedt SJ; Wu L; Williams RR
    Genet Epidemiol; 1987; 4(2):67-76. PubMed ID: 3108070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia].
    Kalina A; Czeizel E; Romics L; Pados G; Reiber I; Dósa A; Hermányi I; Lakatos Z; Tarján J; Kollega-Tarsoly E; Kovács M; Szalai C; Császár A
    Orv Hetil; 1998 Mar; 139(13):755-9. PubMed ID: 9578704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
    Saint-Jore B; Varret M; Dachet C; Rabès JP; Devillers M; Erlich D; Blanchard P; Krempf M; Mathé D; Chanu B; Jacotot B; Farnier M; Bonaïti-Péllié C; Junien C; Boileau C
    Eur J Hum Genet; 2000 Aug; 8(8):621-30. PubMed ID: 10952765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)----glutamine mutation.
    Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1991 Jun; 88(2-3):219-26. PubMed ID: 1892487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.